These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25149422)
1. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients. Prins M; Dutta R; Baselmans B; Brevé JJ; Bol JG; Deckard SA; van der Valk P; Amor S; Trapp BD; de Vries HE; Drukarch B; van Dam AM Acta Neuropathol Commun; 2014 Aug; 2():98. PubMed ID: 25149422 [TBL] [Abstract][Full Text] [Related]
2. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. Foresti ML; Arisi GM; Katki K; Montañez A; Sanchez RM; Shapiro LA J Neuroinflammation; 2009 Dec; 6():40. PubMed ID: 20034406 [TBL] [Abstract][Full Text] [Related]
3. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283 [TBL] [Abstract][Full Text] [Related]
4. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter. Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816 [TBL] [Abstract][Full Text] [Related]
5. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353 [TBL] [Abstract][Full Text] [Related]
6. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes. Parillaud VR; Lornet G; Monnet Y; Privat AL; Haddad AT; Brochard V; Bekaert A; de Chanville CB; Hirsch EC; Combadière C; Hunot S; Lobsiger CS J Neuroinflammation; 2017 Mar; 14(1):60. PubMed ID: 28320442 [TBL] [Abstract][Full Text] [Related]
7. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Sørensen TL; Ransohoff RM; Strieter RM; Sellebjerg F Eur J Neurol; 2004 Jul; 11(7):445-9. PubMed ID: 15257681 [TBL] [Abstract][Full Text] [Related]
8. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus. Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963 [TBL] [Abstract][Full Text] [Related]
9. Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence. Piotrowska A; Kwiatkowski K; Rojewska E; Slusarczyk J; Makuch W; Basta-Kaim A; Przewlocka B; Mika J J Neuroimmunol; 2016 Aug; 297():9-19. PubMed ID: 27397071 [TBL] [Abstract][Full Text] [Related]
10. Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Tanuma N; Sakuma H; Sasaki A; Matsumoto Y Acta Neuropathol; 2006 Aug; 112(2):195-204. PubMed ID: 16733654 [TBL] [Abstract][Full Text] [Related]
11. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350 [TBL] [Abstract][Full Text] [Related]
13. The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Popiolek-Barczyk K; Ciechanowska A; Ciapała K; Pawlik K; Oggioni M; Mercurio D; De Simoni MG; Mika J Mol Cell Probes; 2020 Dec; 54():101671. PubMed ID: 33160071 [TBL] [Abstract][Full Text] [Related]
17. Pathological differences between white and grey matter multiple sclerosis lesions. Prins M; Schul E; Geurts J; van der Valk P; Drukarch B; van Dam AM Ann N Y Acad Sci; 2015 Sep; 1351():99-113. PubMed ID: 26200258 [TBL] [Abstract][Full Text] [Related]
19. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260 [TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 (MCP-1) produced via NF-kappaB signaling pathway mediates migration of amoeboid microglia in the periventricular white matter in hypoxic neonatal rats. Deng YY; Lu J; Ling EA; Kaur C Glia; 2009 Apr; 57(6):604-21. PubMed ID: 18942743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]